Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Neurology
  4. Fine-tuning oligodendrocyte development by microRNAs

Fine-tuning oligodendrocyte development by microRNAs

Frontiers in Neuroscience, 2012 · DOI: 10.3389/fnins.2012.00013 · Published: February 6, 2012

NeurologyGenetics

Simple Explanation

Oligodendrocytes create myelin sheaths around nerve fibers in the central nervous system, which is vital for proper nerve function. Damage to these cells leads to diseases like multiple sclerosis. MicroRNAs (miRNAs) are small molecules that control gene expression and play a crucial role in how oligodendrocytes develop. MiRNAs affect various aspects of oligodendrocyte development, including how they multiply, specialize, and form myelin. Understanding how miRNAs work could help in treating diseases where myelin is damaged. This review discusses how miRNAs regulate myelination and their potential role in demyelinating diseases. It also highlights the connection between miRNAs and the regulatory networks involved in myelination.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Review Article

Key Findings

  • 1
    MicroRNAs (miRNAs) play a critical role in oligodendrocyte development, including cell proliferation, differentiation, and myelin formation.
  • 2
    Specific miRNAs, such as miR-219 and miR-338, are substantially increased at the onset of oligodendrocyte myelination and play a positive role in promoting OPC differentiation.
  • 3
    Dysregulation of miRNAs, particularly miR-219 and miR-338, is implicated in demyelinating diseases like multiple sclerosis, suggesting their potential role in human OL maturation and myelin repair.

Research Summary

This review highlights the role of microRNAs (miRNAs) in fine-tuning oligodendrocyte development, a process crucial for myelination in the central nervous system. The review discusses how specific miRNAs integrate into regulatory circuitries to control oligodendrocyte development in both physiological and pathological conditions, including demyelinating diseases. Understanding miRNA signatures during development and in disease states holds promise for both diagnostic and therapeutic purposes in demyelinating diseases.

Practical Implications

Therapeutic Potential

Targeting specific miRNAs could offer novel therapeutic interventions for myelin repair in demyelinating diseases.

Diagnostic Biomarkers

MiRNA expression profiles can be used as potential biomarkers for diagnosing and monitoring demyelinating diseases like multiple sclerosis.

Understanding Disease Mechanisms

Further research into miRNA function will provide insights into the regulatory networks controlling myelination and the pathogenesis of demyelinating diseases.

Study Limitations

  • 1
    Functions of many identified miRNAs in oligodendrocyte development remain elusive.
  • 2
    Overlapping of miRNAs at same developmental stage are not common due to the different cell sources or stages used (rat and human).
  • 3
    The mechanistic basis for impaired myelin repair in MS is not completely understood.

Your Feedback

Was this summary helpful?

Back to Neurology